Search Within

Christopher G Azzoli

  1. "Paul Paik"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Thoracic Oncology (5)
  4. Surgery (4)
  5. Department of Pathology and Laboratory Medicine (3)
  6. Radiology, Department of (3)

More Groups

People
  1. Camelia Sima (5)
  2. Gregory Riely (5)
  3. Mark Kris (5)
  4. Naiyer Rizvi (5)
  5. Paul Paik (5)
  6. Lee Krug (4)

More People

Years
  1. 2013 (3)
  2. 2012 (1)
  3. 2011 (1)
Publications
  1. Cancer Chemotherapy and Pharmacology (2)
  2. Journal of Thoracic Oncology (2)
  3. Journal of Clinical Oncology (1)
Publishers
  1. Elsevier Inc. (2)
  2. Springer (2)
  3. American Society of Clinical Oncology (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab
    Journal Article

    Hellmann, M. D.; Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers
    Journal Article

    Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Paik, P. K.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
    Journal Article

    Yu, H. A.; Sima, C. S.; Huang, J.; Solomon, S. B.; Rimner, A.; Paik, P.; Pietanza, M. C.; Azzoli, C. G.; Rizvi, N. A.; Krug, L. M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Quantitating pathologic response to neoadjuvant chemotherapy in KRAS-mutated versus nonmutated lung cancers
    Meeting Abstract

    Chaft, J. E.; Paik, P. K.; Sima, C. S.; Kris, M. G.; Krug, L. M.; Azzoli, C. G.; Riely, G. J.; Pietanza, M. C.; Rusch, V. W.; Travis, W. D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase 2 study of weekly albumin-bound paclitaxel (Abraxane ®) given as a two-hour infusion
    Journal Article

    Paik, P. K.; James, L. P.; Riely, G. J.; Azzoli, C. G.; Miller, V. A.; Ng, K. K.; Sima, C. S.; Heelan, R. T.; Kris, M. G.; Moore, E.; more...
    Cancer Chemotherapy and Pharmacology (2011)

    Fulltext@MSK | Save